Bio-Rad Laboratories (BIO) Competitors $264.45 -0.81 (-0.31%) As of 08/8/2025 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BIO vs. MTD, WAT, ILMN, TECH, CRL, BRKR, PACB, HBIO, TMO, and AShould you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry. Bio-Rad Laboratories vs. Its Competitors Mettler-Toledo International Waters Illumina Bio-Techne Charles River Laboratories International Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Bio-Rad Laboratories (NYSE:BIO) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings, profitability and media sentiment. Which has more risk and volatility, BIO or MTD? Bio-Rad Laboratories has a beta of 0.9, indicating that its share price is 10% less volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.34, indicating that its share price is 34% more volatile than the S&P 500. Is BIO or MTD more profitable? Mettler-Toledo International has a net margin of 21.46% compared to Bio-Rad Laboratories' net margin of 12.50%. Bio-Rad Laboratories' return on equity of 4.01% beat Mettler-Toledo International's return on equity.Company Net Margins Return on Equity Return on Assets Bio-Rad Laboratories12.50% 4.01% 2.82% Mettler-Toledo International 21.46%-476.07%26.05% Does the media favor BIO or MTD? In the previous week, Mettler-Toledo International had 17 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 28 mentions for Mettler-Toledo International and 11 mentions for Bio-Rad Laboratories. Bio-Rad Laboratories' average media sentiment score of 0.91 beat Mettler-Toledo International's score of 0.87 indicating that Bio-Rad Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Rad Laboratories 6 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 16 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher valuation and earnings, BIO or MTD? Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBio-Rad Laboratories$2.57B2.79-$1.84B$11.7322.54Mettler-Toledo International$3.87B6.68$863.14M$39.4931.78 Do institutionals and insiders believe in BIO or MTD? 65.2% of Bio-Rad Laboratories shares are held by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are held by institutional investors. 17.1% of Bio-Rad Laboratories shares are held by insiders. Comparatively, 1.9% of Mettler-Toledo International shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Do analysts prefer BIO or MTD? Bio-Rad Laboratories presently has a consensus target price of $333.50, indicating a potential upside of 26.11%. Mettler-Toledo International has a consensus target price of $1,288.89, indicating a potential upside of 2.70%. Given Bio-Rad Laboratories' stronger consensus rating and higher possible upside, equities analysts clearly believe Bio-Rad Laboratories is more favorable than Mettler-Toledo International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bio-Rad Laboratories 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Mettler-Toledo International 0 Sell rating(s) 5 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryMettler-Toledo International beats Bio-Rad Laboratories on 11 of the 16 factors compared between the two stocks. Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIO vs. The Competition Export to ExcelMetricBio-Rad LaboratoriesMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$7.18B$10.57B$5.44B$20.70BDividend YieldN/A2.01%4.61%3.67%P/E Ratio22.5419.8629.7628.45Price / Sales2.7921.90449.1256.07Price / Cash25.5221.7436.4223.21Price / Book1.002.858.184.33Net Income-$1.84B$211.77M$3.26B$996.14M7 Day Performance-7.07%3.02%6.79%1.98%1 Month Performance4.55%2.11%0.93%-0.84%1 Year Performance-18.71%-9.82%28.83%14.36% Bio-Rad Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOBio-Rad Laboratories4.8801 of 5 stars$264.45-0.3%$333.50+26.1%-19.4%$7.18B$2.57B22.547,700MTDMettler-Toledo International3.7603 of 5 stars$1,259.15-0.4%$1,298.50+3.1%-10.1%$26.17B$3.87B31.4017,300WATWaters4.7462 of 5 stars$302.51-0.1%$381.94+26.3%-15.7%$18.00B$2.96B27.457,600Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionILMNIllumina4.8853 of 5 stars$109.88+0.5%$125.89+14.6%-25.4%$17.30B$4.34B-18.109,030TECHBio-Techne4.9171 of 5 stars$58.55-0.4%$69.58+18.8%-31.3%$9.18B$1.21B71.403,100Earnings ReportDividend AnnouncementAnalyst ForecastCRLCharles River Laboratories International4.6439 of 5 stars$179.10+1.2%$174.54-2.5%-26.1%$8.80B$4.05B-275.5420,100Trending NewsEarnings ReportAnalyst ForecastBRKRBruker4.9341 of 5 stars$43.93+4.7%$52.89+20.4%-51.9%$6.66B$3.45B84.4811,396Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionPACBPacific Biosciences of California2.5533 of 5 stars$1.64+6.5%$2.06+25.7%-19.2%$492.13M$154.01M-0.59730News CoverageEarnings ReportAnalyst UpgradeGap UpHBIOHarvard Bioscience4.336 of 5 stars$0.53-6.3%$3.00+466.9%-83.1%$23.40M$94.14M-0.40490Trending NewsUpcoming EarningsTMOThermo Fisher Scientific4.9919 of 5 stars$484.90+1.4%$593.00+22.3%-23.1%$183.04B$42.88B28.05125,000Positive NewsInsider TradeAAgilent Technologies4.69 of 5 stars$119.54-0.5%$139.77+16.9%-16.1%$33.96B$6.51B29.5217,900Positive News Related Companies and Tools Related Companies Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Agilent Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BIO) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIO Stock Alerts